WNT4 and sex development

Sexual Development

Volumn 2, Issue 4-5, 2008, Pages 210-218

  Biason Lauber, A ^a   Konrad, D ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Meyer Rokitansky Kuster Hauser; M llerian ducts; Ovarian development; Syndrome hyperandrogenism; WNT

Indexed keywords

NUCLEAR RECEPTOR DAX 1; STEROIDOGENIC FACTOR 1; TESTOSTERONE; TRANSCRIPTION FACTOR SOX9; WNT4 PROTEIN; WT1 PROTEIN;

CONFERENCE PAPER; FEMALE GENITAL SYSTEM; HORMONE SYNTHESIS; HUMAN; HYPERANDROGENISM; NONHUMAN; OOCYTE DEVELOPMENT; PRIORITY JOURNAL; SEXUAL DEVELOPMENT; SRY GENE;

ANIMALS; FEMALE; HUMANS; MICE; MULLERIAN DUCTS; OVARY; SEXUAL DEVELOPMENT; WNT PROTEINS;

MUS;

EID: 55749084389     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000152037     Document Type: Conference Paper

References (42)

1. Bertrand J, Rappaport R, Sizonenko PC: Pediatric Endocrinology, pp 88-99 (Williams & Wilkins, Baltimore 1993).
2. Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ: A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351:792-798 (2004).
3. Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ: WNT4 deficiency - a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum Reprod 22:224-229 (2007).
4. Britt KL, Findlay JK: Regulation of the phenotype of ovarian somatic cells by estrogen. Mol Cell Endocrinol 202:11-17 (2003).
5. Chand AL, Ponnampalam AP, Harris SE, Winship IM, Shelling AN: Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril 86:1009-1012 (2006).
6. Clement-Ziza M, Khen N, Gonzales J, Cretolle-Vastel C, Picard JY, et al: Exclusion of WNT4 as a major gene in Rokitansky-Kuster-Hauser anomaly. Am J Med Genet A 137:98-99 (2005).
7. Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, et al: Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 286:2328-2331 (1999).
8. De La Chesnaye E, Kerr B, Paredes A, Merchant-Larios H, Mendez JP, Ojeda SR: Fbxw15/Fbxo12J is an F-box protein-encoding gene selectively expressed in oocytes of the mouse ovary. Biol Reprod 78:714-725 (2008).
9. Di Pasquale E, Beck-Peccoz P, Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75:106-111 (2004).
10. Di Pasquale E, Rossetti R, Marozzi A, Bodega B, Borgato S, et al: Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 91:1976-1979 (2006).
11. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, et al: Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 119:408-415 (2006).
12. Domenice S, Corrêa RV, Costa EM, Nishi MY, Vilain E, et al: Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res 37:145-150 (2004).
13. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M: Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127:4277-4291 (2000).
14. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN: Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 8:729-733 (2002).
15. He X, Semenov M, Tamai K, Zeng X: LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 131:1663-1677 (2004).
16. Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O, Vainio S: Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143:4358-4365 (2002).
17. Hughes IA: Female development - all by default? N Engl J Med 351:748-750 (2004).
18. Jeays-Ward K, Hoyle C, Brennan J, Dandonneau M, Alldus G, et al: Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130:3663-3670 (2003).
19. Jordan BK, Mohammed M, Ching ST, Delot E, Chen XN, et al: Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet 68:1102-1109 (2001).
20. Jordan BK, Shen JH, Olaso R, Ingraham HA, Vilain E: Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc Natl Acad Sci USA 100:10866-10871 (2003).
21. Jost A: Hormonal factors in the sex differentiation of the mammalian foetus. Phil Trans R Soc Lond B Biol Sci 259:119-130 (1970).
22. Kovanci E, Rohozinski J, Simpson JL, Heard MJ, Bishop CE, Carson SA: Growth differentiating faxtor-9 mutations may be associated with premature ovarian failure. Fertil Steril 87:143-146 (2007).
23. Liang L, Soyal SM, Dean J: FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes. Development 124:4939-4947 (1997).
24. MacLaughlin DT, Donahoe PK: Sex determination and differentiation. N Engl J Med 350:367-378 (2004).
25. Mandel H, Shemer R, Borochowitz ZU, Okopnik M, Knopf C, et al: SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am J Hum Genet 82:39-47 (2008).
26. McElreavey K, Vilain E, Abbas N, Herskowitz I, Fellous M: A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci USA 90:3368-3372 (1993).
27. McLaren A: Meiosis and differentiation of mouse germ cells. Symp Soc Exp Biol 38:7-23 (1984).
28. Merchant H: Rat gonadal and ovarian organogenesis with and without germ cells. An ultrastructural study. Dev Biol 44:1-21 (1975).
29. Nusse R: Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 130:5297-5305 (2003).
30. Palmer JS, Zhao ZZ, Hoekstra C, Hayward NK, Webb PM, et al: Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab 91:4713-4716 (2006).
31. Pandur P, Lasche M, Eisenberg LM, Kuhl M: Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418:636-641 (2002).
32. Philibert P, Biason-Lauber A, Rouzier R, Pienkowski C, Paris F, et al: Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and Mullerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab 93:895-900 (2008).
33. Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A: NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 81:576-581 (2007).
34. Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM: NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305:1157-1159 (2004).
35. Soyal SM, Amleh A, Dean J: FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development 127:4645-4654 (2000).
36. Stenchever MA, Goldfarb AF: Atlas of Clinical Gynecology, Volume 1: Pediatric and Adolescent Gynecology (Appleton & Lange, U.S. 1998).
37. Su YQ, Sugiura K, Wigglesworth K, O'Brien MJ, Affourtit JP, et al: Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development 135:111-121 (2008).
38. Suwa T, Chen M, Hawks CL, Hornsby PJ: Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. J Endocrinol 178:149-158 (2003).
39. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP: Female development in mammals is regulated by Wnt-4 signalling. Nature 397:405-409 (1999).
40. Wood JR, Ho CK, Nelson-Degrave VL, McAllister JM, Strauss JF 3rd: The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol 63:51-60 (2004).
41. Yao HH: The pathway to femaleness: current knowledge on embryonic development of the ovary. Mol Cell Endocrinol 230:87-93 (2005).
42. Yao HH, Matzuk MM, Jorgez CJ, Menke DB, Page DC, et al: Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230:210-215 (2004).